Holen Sie sich die Stockscreener-App
2.07
0.49%
0.010
Handel nachbörslich:
2.07
Schlusskurs vom Vortag:
$2.06
Offen:
$2.07
24-Stunden-Volumen:
209.93K
Relative Volume:
0.46
Marktkapitalisierung:
$103.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-123.57M
KGV:
-0.6809
EPS:
-3.04
Netto-Cashflow:
$-97.53M
1W Leistung:
+0.98%
1M Leistung:
-0.96%
6M Leistung:
+13.11%
1J Leistung:
+21.05%
1-Tages-Spanne:
$2.06
$2.08
1-Wochen-Bereich:
$2.06
$2.10
52-Wochen-Spanne:
$1.34
$2.17
Hillevax Inc Stock (HLVX) Company Profile
Firmenname
Hillevax Inc
Sektor
Branche
Telefon
(617) 213-5054
Adresse
321 HARRISON AVE, SUITE 500, BOSTON
Vergleichen Sie HLVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
2.07 | 103.26M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-09 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-09 | Herabstufung | Stifel | Buy → Hold |
| 2024-07-08 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-07-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-12-13 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Hillevax Inc Aktie (HLVX) Neueste Nachrichten
Using data filters to optimize entry into HilleVax Inc.2025 Technical Overview & Safe Entry Zone Identification - Newser
HilleVax Inc. stock trend forecastGlobal Markets & Risk Controlled Daily Plans - Newser
How to integrate HilleVax Inc. into portfolio analysis toolsJuly 2025 Earnings & Trade Opportunity Analysis - Newser
Is HilleVax Inc. stock bottoming out2025 Year in Review & Short-Term Trading Opportunity Alerts - Newser
Can swing trading help recover from HilleVax Inc. losses2025 Support & Resistance & Stock Market Timing Techniques - Newser
HilleVax Inc. stock daily chart insights [July 2025 Sector Moves]Free High Conviction Investment Ideas - Newser
Top Risks to Consider Before Buying HilleVax Inc. StockPredictable Return Plan with Entry Guidance - Newser
Can trapped investors hope for a rebound in HilleVax Inc.Monthly Long-Term Market Recap and Summary - Newser
Is HilleVax Inc. meeting your algorithmic filter criteriaTrend Analysis for Safer Market Entries - Newser
Technical analysis overview for HilleVax Inc. stockDay Trading Setup Forecast with Trend Model - Newser
Is HilleVax Inc. stock entering bullish territoryLow Drawdown Stock Screener with Analysis - Newser
How HilleVax Inc. stock performs during market volatilityTechnical Safety Zone Pattern Recognition - Newser
Has HilleVax Inc. found a price floorIn-Depth Stock Trading Volume Analysis - Newser
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Globe and Mail
Real time alert setup for HilleVax Inc. performanceAI Screener for Daily Stock Forecast - Newser
Will HilleVax Inc. stock recover after recent dropFree Long Hold Safe Return Strategy - Newser
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX) - Eastern Progress
XOMA Royalty Announces Dual Acquisitions of HilleVax and LAVA Therapeutics - MSN
Published on: 2025-08-08 19:03:26 - Newser
Shareholder Alert: The Ademi Firm Investigates Whether HilleVax, Inc. Is Obtaining a Fair Price for Its Public Shareholders - New Castle News
Can HilleVax Inc. rally from current levels2-Day Signal Watch with Forecast Outcome - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, YMAB, HLVX on Behalf of Shareholders - The Malaysian Reserve
How HBANM stock compares to its top competitorsIs HilleVax Inc. stock undervalued or overvalued nowMonthly Trade Result and Signal Summary - Newser
HilleVax Reports Second Quarter 2025 Financial Results - Bluefield Daily Telegraph
East Bay’s Xoma adds two more biotechs to its portfolioSan Francisco Business Times - The Business Journals
I'm Staying Neutral On XOMA Royalty After The LAVA And HilleVax Deals - Seeking Alpha
Can volume confirm reversal in HilleVax Inc.AI Intraday Market Movement Prediction Tool - Newser
HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc.HLVX - The Globe and Mail
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of HilleVax, Inc. - Barchart.com
Hillevax Shares Gain on Acquisition Deal with XOMA Royalty - MSN
Published on: 2025-08-05 00:26:07 - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HNI, LVTX, HLVX on Behalf of Shareholders - The Malaysian Reserve
HilleVax Announces Merger Agreement with XOMA: Unlocking Potential with TipRanks Premium - AInvest
HilleVax to be Acquired by XOMA Royalty Under New Merger Agreement - AInvest
Options Data Show Bullish Bias in HilleVax Inc.AI Screening for Swing Trade Picks Finds Momentum - metal.it
Behind HilleVax Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com
Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders - The Malaysian Reserve
Xoma strikes deals to buy struggling biotechs HilleVax, Lava - BioPharma Dive
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq – HLVX), Steelcase Inc. (NYSE – SCS), LAVA Therapeutics N.V. (Nasdaq – LVTX), Arcadia Biosciences, Inc. (Nasdaq – RKDA) - Morningstar
Latham Advises HilleVax Acquisition XOMA Royalty US1 95 Cash Per Share Plus Contingent Value Right - Latham & Watkins LLP
HLVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HilleVax, Inc. Is Fair to Shareholders - Business Wire
HilleVax Enters into a Definitive Agreement to be Acquired - GlobeNewswire
Hillevax stock rises after XOMA Royalty announces acquisition By Investing.com - Investing.com South Africa
Hillevax stock rises after XOMA Royalty announces acquisition - Investing.com
Finanzdaten der Hillevax Inc-Aktie (HLVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):